22 January 2021>: Original Paper
Effect of Everolimus with Low-Dose Tacrolimus on Development of New-Onset Diabetes After Transplantation and Allograft Function in Kidney Transplantation: A Multicenter, Open-Label, Randomized Trial
Hyung Duk Kim 1BEF , Ji-Yeun Chang 1CDE , Byung Ha Chung 1AB , Chan-Duck Kim 2B , Sang-Ho Lee 3B , Yeong Hoon Kim 4B , Chul Woo Yang 1ADG*DOI: 10.12659/AOT.927984
Ann Transplant 2021; 26:e927984
Figure 1 Overview of study protocol. The KT recipients who signed informed consents were allocated with randomization into 2 groups: “EVL group” or “TAC group,” at 6 months after KT. KT – kidney transplantation; Tac – tacrolimus; EVL – everolimus; D – day; M – month.